Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lonn

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|October 13, 2001
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)S S Anand, S Yusuf, R Jacobs, et al.
Journal of the American College of Cardiology|July 1, 1992
In vitro high resolution intravascular imaging in muscular and elastic arteriesG R Lockwood, L K Ryan, A I Gotlieb, et al.
Circulation|October 3, 2001
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramiprilJ Mathew, P Sleight, E Lonn, et al.
Circulation|February 22, 2001
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)E Lonn, S Yusuf, V Dzavik, et al.
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Journal of Internal Medicine|April 16, 2015
Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studiesM Böhm, H Schumacher, D Linz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 12, 2012
Increased cardiovascular risk after pre-eclampsia in women with dysglycaemiaS D McDonald, S Yusuf, M W Walsh, et al.
Indian Heart Journal|May 8, 2001
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE)S S Anand, S Yusuf, V Vuksan, et al.
Lancet (London, England)|November 9, 2000
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)S S Anand, S Yusuf, V Vuksan, et al.
Journal of Cardiac Failure|September 7, 2023
Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION StudyEwa Straburzynska-Migaj, M Senni, R Wachter, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|October 13, 2001
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)S S Anand, S Yusuf, R Jacobs, et al.
Journal of the American College of Cardiology|July 1, 1992
In vitro high resolution intravascular imaging in muscular and elastic arteriesG R Lockwood, L K Ryan, A I Gotlieb, et al.
Circulation|October 3, 2001
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramiprilJ Mathew, P Sleight, E Lonn, et al.
Circulation|February 22, 2001
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)E Lonn, S Yusuf, V Dzavik, et al.
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Journal of Internal Medicine|April 16, 2015
Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studiesM Böhm, H Schumacher, D Linz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 12, 2012
Increased cardiovascular risk after pre-eclampsia in women with dysglycaemiaS D McDonald, S Yusuf, M W Walsh, et al.
Indian Heart Journal|May 8, 2001
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE)S S Anand, S Yusuf, V Vuksan, et al.
Lancet (London, England)|November 9, 2000
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)S S Anand, S Yusuf, V Vuksan, et al.
Journal of Cardiac Failure|September 7, 2023
Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION StudyEwa Straburzynska-Migaj, M Senni, R Wachter, et al.
Pageof 4